MedPath
Found 2253 clinical trials|View Analysis
Sort by:
Need a comprehensive medical report on "Boehringer Ingelheim"?
Analyze the latest clinical research and treatment options
Summarize scientific findings from medical journals

Safety, Tolerance, and Pharmacokinetics of Single Rising Oral Doses of BILB 1941 ZW Solution in Healthy Male Subjects, Followed With Bioavailability Comparison of BILB 1941 ZW Tablet and Solution Formulation Administered With or Without Food

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: BILB 1941 ZW - single rising dose part
Drug: Placebo
Drug: BILB 1941 ZW - tablet
Drug: BILB 1941 ZW - solution
Other: standardized breakfast
First Posted Date
2014-10-06
Last Posted Date
2014-10-06
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
56
Registration Number
NCT02256787

Study to Investigate the Effect of KUC 7483 CL on the QT/QTc Interval of the ECG in Comparison to Placebo and Moxifloxacin in Healthy Male and Female Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Treatment B
Drug: Treatment C
Drug: Placebo
Drug: Treatment A
First Posted Date
2014-10-06
Last Posted Date
2014-10-06
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
39
Registration Number
NCT02256735

In Vivo Specificity of KUC 7483 CL Co-administered With Bisoprolol, Propranolol, and Acipimox in Healthy Male Subjects

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2014-10-06
Last Posted Date
2014-10-06
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
12
Registration Number
NCT02256722

Effect of Different Boosting Agents on Pharmacokinetics of BILR 355 BS Dissolved in Polyethylene Glycol 400 (PEG 400) in Healthy Male Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: BILR 355 BS
Other: Grapefruit juice
First Posted Date
2014-10-06
Last Posted Date
2014-10-06
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
44
Registration Number
NCT02257008

Safety, Pharmacokinetics, and Pharmacodynamics of BIRT 2584 XX Administered as Multiple Doses and Safety and Pharmacokinetics of BIRT 2584 XX Administered With and Without Food as Single Dose to Healthy Male Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: BIRT 2584 XX - single dose
Drug: BIRT 2584 XX - multiple escalating dose
Drug: Placebo
Other: high caloric meal
First Posted Date
2014-10-06
Last Posted Date
2014-10-06
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
74
Registration Number
NCT02256761

Pharmacokinetic Interaction Between Tipranavir and BILR 355 BS Plus Ritonavir in Healthy Male Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2014-10-06
Last Posted Date
2014-10-06
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
34
Registration Number
NCT02257021

Study to Evaluate the Effect of Multiple Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Midazolam in Healthy Male Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2014-10-06
Last Posted Date
2014-10-06
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
20
Registration Number
NCT02256748

Study of Pharmacokinetic Interaction Between Kaletra® (LPV/r) and BILR 355 BS Plus Ritonavir in Healthy Subjects

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2014-10-06
Last Posted Date
2014-10-06
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
34
Registration Number
NCT02256826
© Copyright 2025. All Rights Reserved by MedPath